Rohun, J.; Dudzik, D.; Raczak-Gutknecht, J.; Wabich, E.; Młodziński, K.; Markuszewski, M.J.; Daniłowicz-Szymanowicz, L.
Metabolomics in Atrial Fibrillation: Unlocking Novel Biomarkers and Pathways for Diagnosis, Prognosis, and Personalized Treatment. J. Clin. Med. 2025, 14, 34.
https://doi.org/10.3390/jcm14010034
AMA Style
Rohun J, Dudzik D, Raczak-Gutknecht J, Wabich E, Młodziński K, Markuszewski MJ, Daniłowicz-Szymanowicz L.
Metabolomics in Atrial Fibrillation: Unlocking Novel Biomarkers and Pathways for Diagnosis, Prognosis, and Personalized Treatment. Journal of Clinical Medicine. 2025; 14(1):34.
https://doi.org/10.3390/jcm14010034
Chicago/Turabian Style
Rohun, Justyna, Danuta Dudzik, Joanna Raczak-Gutknecht, Elżbieta Wabich, Krzysztof Młodziński, Michał J. Markuszewski, and Ludmiła Daniłowicz-Szymanowicz.
2025. "Metabolomics in Atrial Fibrillation: Unlocking Novel Biomarkers and Pathways for Diagnosis, Prognosis, and Personalized Treatment" Journal of Clinical Medicine 14, no. 1: 34.
https://doi.org/10.3390/jcm14010034
APA Style
Rohun, J., Dudzik, D., Raczak-Gutknecht, J., Wabich, E., Młodziński, K., Markuszewski, M. J., & Daniłowicz-Szymanowicz, L.
(2025). Metabolomics in Atrial Fibrillation: Unlocking Novel Biomarkers and Pathways for Diagnosis, Prognosis, and Personalized Treatment. Journal of Clinical Medicine, 14(1), 34.
https://doi.org/10.3390/jcm14010034
